Singapore markets closed
Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,139.83 +60.97 (+0.75%) Bitcoin USD
63,794.25 +732.66 (+1.16%) CMC Crypto 200
1,388.64 -7.89 (-0.57%)
Genesis Healthcare, Inc. (GENN)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 12:46PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.04M |
| Enterprise value | 3.60B |
| Trailing P/E | 1.29 |
| Forward P/E | 0.01 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.00 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 0.92 |
| Enterprise value/EBITDA | 26.41 |
Trading information
Stock price history
| Beta (5Y monthly) | -0.48 |
| 52-week change 3 | -83.33% |
| S&P500 52-week change 3 | 22.36% |
| 52-week high 3 | 0.3756 |
| 52-week low 3 | 0.0001 |
| 50-day moving average 3 | 0.0013 |
| 200-day moving average 3 | 0.0016 |
Share statistics
| Avg vol (3-month) 3 | 14.53k |
| Avg vol (10-day) 3 | 46.71k |
| Shares outstanding 5 | 111.73M |
| Implied shares outstanding 6 | 1.86B |
| Float 8 | 111.79M |
| % held by insiders 1 | 0.00% |
| % held by institutions 1 | 0.03% |
| Shares short (15 Mar 2021) 4 | 2.3M |
| Short ratio (15 Mar 2021) 4 | 0.21 |
| Short % of float (15 Mar 2021) 4 | 2.85% |
| Short % of shares outstanding (15 Mar 2021) 4 | 1.38% |
| Shares short (prior month 12 Feb 2021) 4 | 1.18M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2020 |
| Most-recent quarter (mrq) | 31 Dec 2020 |
Profitability
| Profit margin | -1.51% |
| Operating margin (ttm) | -7.36% |
Management effectiveness
| Return on assets (ttm) | -3.86% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 3.91B |
| Revenue per share (ttm) | 34.92 |
| Quarterly revenue growth (yoy) | -19.10% |
| Gross profit (ttm) | N/A |
| EBITDA | -161.94M |
| Net income avi to common (ttm) | -58.96M |
| Diluted EPS (ttm) | -0.0500 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 212.07M |
| Total cash per share (mrq) | 1.89 |
| Total debt (mrq) | 3.81B |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.23 |
| Book value per share (mrq) | -7.35 |
Cash flow statement
| Operating cash flow (ttm) | 315.73M |
| Levered free cash flow (ttm) | -143.07M |
© 2024 Yahoo. All rights reserved.